– IP firm key contributor to business strategy, client satisfaction of BioAcceleration™ company –
SAN DIEGO, Calif., April 6, 2007. Capia IP has been retained to provide business, licensing, legal options and intellectual property support for BioAtla’s BioAcceleration™ protein therapeutics services business.
Ms. Carolyn Anderson, founder of Capia IP, stated “more and more companies understand that intellectual property strategy is a key component of business strategy. IP is literally the company’s jewels and the early discussion and implementation of IP strategy can add tremendous assets to a company’s portfolio as well as reduce long term costs by identifying and reducing unnecessary and distracting issues.”
Capia IP expertise ranges from biotechnology, pharmaceutical, agricultural, chemical and industrial technologies.
The two companies expect that their collaboration will allow rapid analysis and identification of potential issues for both BioAtla’s internal programs and partnering projects.
About BioAtla, LLC
BioAtla, LLC is a global, biology outsourcing services provider based in San Diego, CA with significant research operations in San Diego, New York, Beijing and in 2011, Shanghai, China. We are a pioneer in BioAcceleration™ – using a global infrastructure to deliver cost-efficient access to state-of-the art technologies and services, maximizing antibody and other protein product development opportunities for our client partners.
Our exclusive manufacturing partnership with China-based BioDuro, a PPD company, and our intellectual property partnership with Capia IP translates our industry know-how and thought leadership into tangible, ownable results for our clients.
About Capia IP
Capia IP collaborates with enterprises and individuals in life sciences to strategically manage and maximize the value of their intellectual property needs in view of their business. As a dedicated business partner of BioAtla, LLC, Capia IP offers BioAtla client partners comprehensive IP services to create, own and protect their results.
For more information, please visit www.bioatla.com or contact:
Carolyn Anderson, Executive Vice President
858-558-0708 ext. 0
SOURCE BioAtla, LLC / Capia IP